申请人:Kali-Chemie Pharma GmbH
公开号:US04672062A1
公开(公告)日:1987-06-09
3-amino-2,3-dihydro-1-benzoxepine compounds corresponding to the general Formula I ##STR1## wherein R.sub.1 and R.sub.2 may each be hydrogen, halogen, lower alkyl or lower alkoxy, or if one of R.sub.1 and R.sub.2 is hydrogen, the other may also be nitro or trifluoromethyl, R.sub.3 represents hydrogen or a lower alkyl group which optionally may be substituted by hydroxy, lower alnoxy, an optionally substituted phenyl group or an optionally substituted amino group, and R.sub.4 represents hydrogen or lower alkyl, or R.sub.3 and R.sub.4 together with the nitrogen atom form a 5 or 6 member heterocycle. The compounds exhibit pharmacological, especially antidepressive, activity.
对应于一般公式I的3-氨基-2,3-二氢-1-苯并氧杂环化合物,其中R.sub.1和R.sub.2可以分别是氢、卤素、低烷基或低烷氧基,或者如果R.sub.1和R.sub.2中的一个是氢,则另一个也可以是硝基或三氟甲基,R.sub.3表示氢或者一个低烷基,该低烷基可以选择性地被羟基、低烷氧基、一个可选择性地取代的苯基或一个可选择性地取代的氨基基团所取代,而R.sub.4表示氢或低烷基,或者R.sub.3和R.sub.4与氮原子一起形成一个5或6元杂环。这些化合物表现出药理学特性,特别是抗抑郁活性。